Antidote: Mixed messages on e-cigarettes

Share this article:
Marc Siegel, MD
Marc Siegel, MD

It has been a difficult month for e-cigarettes, mostly because the news media doesn't do a great job with mixed messages. First came a study from CDC showing that the rate of e-cigarette use in middle schoolers and high schoolers has doubled over the past year, with the vast majority of these users also using tobacco. The CDC's justified concern was that e-cigarettes could be a gateway drug for tobacco use. Once addicted to nicotine, an e-cigarette user could be simultaneously smoking cigarettes. Despite the fact that 12 states already ban e-cigarette sales to minors, no one is listening. Teens simply borrow e-cigs from their parents, or buy them on the internet.

So the initial media message was that e-cigarettes were bad. But lost in this message was the information that they do in fact help many recalcitrant smokers to cut down, if not to quit. Luckily, a week later another report came out, this time a well-done randomized trial from Australia published in the prestigious British journal Lancet, which demonstrated that e-cigarettes were at least as effective, and probably more effective, than the nicotine patch when it comes to smoking cessation. This makes sense when you consider that most smokers don't just have a nicotine addiction, they also have an oral fixation.

So how to deal with a burgeoning nicotine industry out of control, combined with the fact that there is also a medical usefulness?  FDA regulations may be part of the answer, but are not likely to go far enough to affect real change. I have suggested making e-cigarettes prescription-only to make the point that they contain a dangerous chemical, nicotine, but the chances of this actually happening are about the same as me winning the lottery.

The best we can probably do is understand e cigarettes as both a good guy and a bad guy simultaneously. If we can convey this mixed message in the news media, it will be a major success in terms of public information.

Share this article:
You must be a registered member of MMM to post a comment.

Next Article in Agency Gallery

Email Newsletters

MM&M Future Leaders

Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Agency Gallery

Agency Business briefs: June 2014

Agency Business briefs: June 2014

News on Publicis, Palio+Ignite, PulseCX, McCann HumanCare and GolinHarris

It's time to replace the FDA, says Newt Gingrich

It's time to replace the FDA, says Newt ...

Former Speaker of the House and presidential candidate Newt Gingrich has declared that it's time to replace FDA

Agency Business briefs: May 2014

Agency Business briefs: May 2014

Newson ID Media, Frontline Medical Communications and ContextMedia